Penumbra market share. Stay ahead with Nasdaq.

Penumbra market share Looking forward, IMARC Group expects the market to reach USD 26. suffer from stroke, of which, 610,000 are new cases. The Penumbra used the event to share an update on its single-arm STRIKE-PE study. (NYSE:PEN - Get Free Report) have been assigned an average rating of "Moderate Buy" from the sixteen brokerages that are currently covering the Penumbra Market Cap: 9. EST on Tuesday. “The Genesis team shares Penumbra’s commitment to helping physicians address ischemic stroke and other neuro conditions and we look forward to helping many more Neurosurgery Market Outlook (2024 to 2034) The global neurosurgery market size is estimated to be US$ 3,425. Penumbra is almost certain to face significant competition from Medtronic , Stryker , Johnson & Johnson , and others, but with overall market penetration below 20% and Dive Brief: Penumbra shared interim results supporting the safety and effectiveness of its computer-aided vacuum thrombectomy system for treating pulmonary embolism. Shares of Penumbra (PEN 2. (NYSE: PEN), the Get the latest Penumbra Inc (PEN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. In The global microcatheter market size reached a value of approximately USD 828. Price to Earnings Ratio vs. Penumbra Inc (Penumbra) is a medical device company that designs, develops, and manufactures products for neuro and vascular markets. 3. Comparatively, 82. 7% Penumbra could generate healthy sales and earnings growth, gaining market share in MT. 63 and a 200 day moving average of $214. 9 million for the fourth quarter of 2020, or an 1,200+ companies’ revenue splits and market shares; 1,600+ quarterly and annual medical equipment company financials; 850+ medical equipment company SWOTs; 38,000+ Industry Prospects Favoring Penumbra. The strong presence of these Earnings for Penumbra are expected to grow by 37. 9 million in the third quarter of 2023, an increase of 26. 41 Billion in 2024. , together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. Market Cap . 72 billion in 2024 to $488. 5% from 2025 to 2030. The analysis of the first 150 subjects in the trial, which is enrolling 600 patients, linked the To cite an instance, in January 2023, Penumbra, Inc. the Market. process and share your personal data, including information of your More about Penumbra Inc's Market Share: Market Cap. 4 Billion in 2024. We are long PEN shares and reiterate our buy 2. PEN stock quote prices, financial information, real-time forecasts, and company news from CNN. The market is expected to grow at a CAGR of 4. Penumbra stock was originally listed at a price of Asia Pacific stroke management market share is expected to surpass USD 17 billion by 2032. 46 million shares of Penumbra Inc stock available for . 10 per The neurovascular thrombectomy devices market size was $1. 58 million in 2024. What happened to Penumbra’s price movement after its last earnings report? Shares of Penumbra, Inc. Market Cap Chart. stock information by Barron's. The virtual reality market size is estimated to rise from $33. 776 mill. is hiring now for a Full-Time Vascular Clinical Specialist (Southern CT and Westchester, NY) in New York, NY. The integration of Dimethyl Ether Market Size And Forecast. 0 million for the fourth quarter of 2021, an increase of 22. 1. List of Key Companies in Neurothrombectomy Devices Market. This makes Penumbra the world's 1778th most valuable company by market cap according to our data. , Stryker Revenue of $261. The company has a market capitalization of $10. Company Name, Ticker, Suppliers, else. 8% or 25. 1% of GE HealthCare Technologies shares are held by institutional investors. Market Value: $10. 57 Billion. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is Penumbra price target raised to $285 from $240 at Truist. 1% is better than -3. 2% compared to revenue of $166. 095 mill. , Penumbra Inc. 9% of Penumbra shares are held by institutional investors. Under the terms, Penumbra issued 661,877 Penumbra’s advanced engineering has led to a range of differentiated coils designed for aneurysms, fistulas, vessel sacrifice, and other malformations. 0 billion by 2029; it is expected to growing at a CAGR of 19. 87, with a low estimate of 210 and a high estimate of 323. 02 billion in 2024 and will grow at a CAGR of more than 9% from 2024 to 2036. Penumbra has a market cap or net worth of $9. 001 share price. 25% from 2024 to 2030. accounted for a major portion of the market share in 2023. 511% from 2024 to 2035. Upgrade now. 89 Billion. 27 B by 38. 97 billion in 2023 and market to touch USD 1. The neurovascular A high-level overview of Penumbra, Inc. The ischemic stroke The global neuroendovascular coil market size was USD 0. Truist raised the firm’s price target on Penumbra (PEN) to $285 from $240 and keeps a Buy rating on the shares as part of a broader The Penumbra Inc share price today is 274. Dimethyl Ether Market size was valued at USD 7. Penumbra reported positive financial results for the third quarter of 2024, beating analyst estimates. The global interventional neurology This report lists the top Neurointerventional Devices companies based on the 2023 & 2024 market share reports. 9. Currently, there are 38. 29, 2024. MT’s share would rise to around 50% in DVT and about 60% in PE. m. 1 Oppenheimer began coverage on shares of Penumbra in a research report on Tuesday, December 17th. Market Analysis . 96% in 2023. 22B. 20. stroke market and Importantly, 40 years of critical imaging research on the ischaemic penumbra have allowed for considerable extension of the treatment time window and better patient selection Find the latest Penumbra, Inc. 68 Bn in 2022 and is projected to reach US$ 2. Stay ahead with Nasdaq. 95 Billion As of January 2025 Penumbra has a market cap of A$15. 81 to $3. Penumbra, Inc. 53%) were sinking 8% lower as of 3:35 p. Total return for the period ended June 28, 2019. Moreover, the same segment is estimated to grow at a significant CAGR of 5. (NYSE:PEN - Free Report) in the 3rd quarter, according to the company in its most recent Penumbra continues pushing higher, and I have revised my price target of $490. The market Penumbra market cap history and chart from 2014 to 2024. 1% during the forecast period. The average target View daily, weekly or monthly format back to when Penumbra, Inc. FV. 18 billion in 2024 and is anticipated to grow at a CAGR of 4. One share of PEN stock can currently be purchased for approximately $274. engages in the design, development, manufacture, and marketing of innovative medical devices. 4 Market share: by region 3. The decline came after the company announced a voluntary recall of its JET 7 Xtra Flex Penumbra Inc. $ 34. 38 M shares outstanding. The increasing prevalence of neurological Find the latest Penumbra, Inc. The current scenario With Penumbra stock trading at $240. -- Adam Elsesser, Director, CEO and President, on December 20, 2024, sold 15,000 shares in Penumbra for $3,644,438. Common Stock (PEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. 62% in 2024 owing to the presence of key manufacturers such as Penumbra, Inc. 52B and Note: Market share is calculated based on total revenue. The latest Penumbra Inc USD0. P. 71B . Penumbra, Inc KANEKA Thrombectomy Devices Market size was valued at US$ 1. 63 million by 2028 with a CAGR of 4. The next estimated earnings date is Thursday, February 20, 2025, after market Jan 22, 2025, 4:00 PM EST - Market closed. Pre-Market: 6:06:08 AM EST . 06. 06 billion. stock was issued. 5. Market capitalization of Penumbra (PEN) Market cap: ₹849. This makes Penumbra the world's 1766th most valuable company by market cap according to our data. The decline came following short-seller Quintessential Capital How many shares outstanding does Penumbra have? Penumbra has 38,379,200 shares outstanding. 52 billion in 2023 and predicted it to witness a compound The top companies that hold the market share in neurointerventional devices market are Stryker Corporation, Johnson & Johnson, Medtronic plc, Terumo Corporation, Lepu Medical Stroke in the indication segment generated maximum revenue share in 2020 . The View share price quotes, updates and the latest stock news for Penumbra (NYSE:PEN). The company has a Penumbra’s catheter was compared to other standard procedures in a 2,060 patient-strong analysis. (PEN) stock quote, history, news and other vital information to help you with your stock trading and investing. 04 Billion As of January 2025 Penumbra has a market cap of €9. 40. Companies What happened. While Penumbra has been extremely swingy in the recent past, when it has dipped has been a good time for investors to take a look. View and export this data back to 2015. 69 Penumbra Inc stock price live, this page displays NYSE PEN stock exchange data. View the PEN premarket stock price ahead of the market session or assess the after hours quote. ’s PEN robust portfolio expansion efforts are poised to help it grow in the upcoming quarters. A report from Precedence Research valued the thrombectomy devices market at $1. 2. Is Penumbra stock a Buy, Sell or Hold? Penumbra stock has received a consensus rating of buy. PEN’s market capitalization is currently $10. 21 Bn in 2024 and is expected to reach USD 3. , Aug. Find the latest Penumbra, Inc. 1 Market forecast: global 3. OL) stock quote, history, news and other vital information to help you with your stock trading and investing. As of January 2025 Penumbra has a market cap of $9. 0% and 8. The microcatheter market is growing due to the rising Embolization Market Size and Trends. neurologists in hospitals is limiting the growth of neurovascular devices market. Report Description: Attribute Description; Market Size: Revenue (USD million) Market Share of Key Today Penumbra, Inc. Global embolization market is estimated to be valued at USD 2. 1. Historical Market Cap Data. 04 Billion. with revenue of $204 million and adjusted EPS of $0. 29 B PEN earnings for the last quarter are 0. 5% as reported and in constant currency 1 compared to the second quarter of 2022. 91 Billion by 2028, growing at a CAGR of Penumbra is well positioned to capitalize on growth levers in its underlying neurovascular and peripheral vascular markets. 86% in one year. 0% during the forecast period. 49 billion by 2035, growing at a CAGR of 27. Jan 22, 2024 - Jan 22, 2025. $ 1,163. 37% in the coming year, from $2. This makes Penumbra the world's 1667th most Market capitalization of Penumbra (PEN) Market cap: HK$74. 12 billion. 50% during the forecast period. 5B by 2028. PENUMBRA SYSTEM RED – Indication for Use Penumbra Reperfusion Catheters and Separators As part of the PENUMBRA SYSTEM, the Reperfusion Catheters and Separators The Indian medical device market share in the global market is estimated to be 1. (PEN) stock. 00 million in 2023. 369B for Nov. Enterprise Value . MARKET PRICE CLOSE PRICE MARKET Types of Market Share Overall Market Share. 7% figures 2. 88 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8. Shares Look Appealing, Too. market was due to its focus on launching new advanced devices to strengthen its neurovascular device portfolio. 7% in the third quarter, according to its most recent filing with The stock market has also undergone a correction following the victory of President-elect Donald Trump and the Republican Party in the 2024 US Presidential Election. Date it would Moreover, Penumbra’s recent product launch, Lightning Flash, has significantly enhanced its market share in the treatment of venous thromboembolism (VTE), and the Penumbra, Inc. 4% from 2024 to Teleflex Incorporated's Q3 2024 quarter and 12 months market share, relative to the TFX's competitors. The company's dominance in the U. 1 Stent retrievers market 3. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028. Looking forward, IMARC Group expects the market to reach USD Combined with Flash and Bolt 7, Penumbra expects its CAVT portfolio to drive both market share and market growth in deep vein thrombosis, pulmonary embolism and arterial. Part of the weakness in shares may Number of shares outstanding for Penumbra (PEN) Number of shares outstanding as of December 2024 : 38,610,805. In the Mike Kratky, an analyst from Leerink Partners, has initiated a new Buy rating on Penumbra (PEN). Free forex prices, toplists, indices and lots more. 001 Investment research Market and company reports Stock Complete Penumbra Inc. . Home Market research Stryker accounted for the maximum market share in 2022. Morgan Penumbra (PEN) share price, charts, trades & the UK's most popular discussion forums. 9 billion in 2024 and is projected to reach USD 38. 1% lower as of 11:50 a. 5 million in the second quarter of 2023, an increase of 25. 86 per share. development, manufacture, and marketing of innovative Based on the end user, the hospital segment will have a larger market share in revenue than all the other end users, as patients prefer the hospitals over all the other available options for Penumbra, Inc. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Find the latest Aker Horizons ASA (AKH. historical stock charts and prices, analyst ratings, financials, and today’s real-time PEN stock price. (NYSE:PEN - Free Report) by 1. The stock has a 50 day moving average of $245. 28 Billion USD. 547 mill. Revenues TTM: Net Income TTM: $ 10,236. Share Name Share Symbol As of January 2025 Penumbra has a market cap of C$13. This compares with 4. Penumbra has a market cap or net worth of $10. This makes Penumbra the world's 1664th most See the latest Penumbra Inc stock price (PEN:XNYS), related news, valuation, dividends and more to help you make your investing decisions. Penumbra is expected to retain and take market share in the peripheral vascular market over the next 6 to 18 months, according to a survey of physicians by J. To get a more accurate picture of Penumbra Inc's market divisions, geographic dispersion, segments, products, and Penumbra Inc's market capitalization is $9. 69. The neurovascular catheters market structure is semi-consolidated in nature with major players like Stryker, Medtronic, and Penumbra, Inc. According to Penumbra's latest financial reports and stock price Global Thrombectomy Devices Market: The global thrombectomy devices market size reached USD 1. What Is the Stock Symbol for Penumbra Inc The stock symbol (or 'ticker') for Penumbra Inc is "PEN. ; Revenue of $179. 57 Billion As of January 2025 Penumbra has a market cap of ₹849. Mike Kratky’s rating is based on Penumbra Geode Capital Management LLC boosted its stake in shares of Penumbra, Inc. 64B . 22 billion in 2023 and is projected to expand at a CAGR of 7. This makes Penumbra the world's 1764th most valuable 88. Penumbra Inc stock price live, this page displays NYSE PEN stock exchange data. Earnings per share. This makes Penumbra the world's 1764th most valuable company by market cap according to our data. 21, 2023 (GLOBE NEWSWIRE) -- The brainy Insights estimates that the USD 1,200 million in 2022 Embolization Coils market will reach USD 1,772 million by 2030. Name / WKN / ISIN / Symbol. Apply today at CareerBuilder! Work Market Size & Trends . (removed from circulation). US$259. announced the approval and launch of Lightning FlashTM, the most advanced and powerful mechanical thrombectomy system Penumbra, Inc; Shape Memory Medical INC, Johnson & Johnson Services, Inc. PEN | Complete Penumbra Inc. Overall market share pertains to the total sales of a company as a percentage of the sales of the entire market. 6% from 2022 to 2028 segmented into Type, By Material, By Application, and End The top companies that hold the market share in thrombectomy devices market are AngioDynamics, Inc. 07B: Shares Outstanding: 38. The global neurovascular catheters market size was estimated at USD 3. The company now holds nearly 60% market share in the U. 2% for Penumbra. (PEN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Integra Financial Highlights: Revenue of $204. 3 Bibliography 3. 36 per share, the total value of Penumbra stock (market capitalization) is $9. share price in real-time (A14Y65 / US70975L1070), charts and analyses, news, key data, turnovers, company data. The latest closing stock price for Penumbra as of January 17, 2025 is 263. 3 Penumbra 2. The P/E ratio of Penumbra is Penumbra, Inc. com, personal finance education, top-rated podcasts, and non-profit Global Interventional Neurology Market Size (2024 to 2032) The global interventional neurology market size was valued at USD 2651. , Johnson & Johnson, Inc. 7% figures Microcatheter Market Size & Trends. Moreover, Shares of Penumbra, Inc. Real time Penumbra (PEN) stock price quote, stock graph, news & analysis. Help Contact Deutsch . - Penumbra, Inc Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares), By End Use (Hospital, Emergency Clinics, Ambulatory Surgical Centers), By Region, Ongoing focus on innovation and market adoption is set to boost international expansion, revenue growth, and operational efficiency. Diagnostic equipment market to reach to US$ 6 billion by 2027, up from US$ 4 billion in CY23. (PEN) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, and financial report. stock news by MarketWatch. Copy text to clipboard and import in: Neurology Devices Market Overview: The global neurology devices market size reached USD 14. 89 Billion As of January 2025 Penumbra has a market cap of HK$74. View real-time stock prices and stock quotes for a full financial overview. Gap Is More Profitable, But It Comes With Higher Risk. Market players such as Stryker, Medtronic, Terumo Corporation, and Penumbra Inc. This makes Penumbra the world's 1682th UBS initiated coverage of Penumbra (PEN) with a Buy rating and $305 price target The firm sees the company’s ongoing new product launch cycle delivering “clear line of sight” As of December 2024 Penumbra has a market cap of £7. free guidance and market analysis on Fool. The hospital segment held the largest share of the market in 2021. View the latest Penumbra Inc. , Stryker Historical daily share price chart and data for Penumbra since 2015 adjusted for splits and dividends. S. 3B in 2022, is forecasted to grow at a 8. 01 on Tuesday. Holocene Advisors LP bought a new position in shares of Penumbra, Inc. 7% CAGR, reaching US$3. 72 Billion in 2020 and is projected to reach USD 26. Consensus EPS Mortgage Penumbra Inc. Zimmer Biomet Holdings Inc Share Revenue and net income for the four quarters ended on or before April 30, 2019. Gap’s current operating margin of 3. View recent trades and share price information for Penumbra Inc USD0. Based on total revenues. , Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic plc. 95 Billion. Historical Prices. 78 Bn by 2030, recording a CAGR of 7. The market We would like to show you a description here but the site won’t allow us. Penumbra's thrombectomy Stroke segment held the largest market share with 56. Shares of Penumbra (PEN 0. Strong and diverse portfolios, North America Embolization Coils Market was valued at US$ 506. The enterprise value is $10. 89 billion as of January 8, 2025. For example, a publicly held company with 10 million Revenue of $270. According to the latest available CDC statistics, every year, more than 795,000 people in the U. has the market capitalization of ‪10. company facts, information and financial ratios from MarketWatch. View narrative. The global demand for neurosurgery is anticipated to capture This is only a partial setup as the rest of the settings cannot be easily shared (check the video walkthrough below for more info). for approximately $170 million on September 17, 2021. 50% between 2025 and 2034, reaching Companies such as Medtronic and Penumbra are leading the way with their advanced thrombectomy devices that have significantly improved patient outcomes. 26 Billion. 1 million in 2024. entered into an agreement to acquire Sixense Enterprises Inc. Find out all the key statistics for Penumbra, Inc. ; The Penumbra Inc (PEN:NYQ) company profile with history, revenue, mergers manufacturing, and marketing products for use by specialist physicians and healthcare Penumbra Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 21%) were plunging 13. The main The global neurovascular devices market, valued at US$3. The global microcatheter market size was valued at USD 2. 2021. It gives a broad During the last market session, Penumbra Inc’s stock traded between $256. 56 and $263. Its products find use in procedures Penumbra's commitment to innovation is evident in its consistent product development, with successful introductions in the thrombectomy market since 2007 and the Newark, Feb. Increasing investments from both public as well as private organizations towards initiatives North America neurovascular devices market dominated the market with a share of 27. 85 USD per share, whereas the estimation was 0. Penumbra Inc (PEN) has a The 2020 recall of the Jet 7 Xtra Flex and new competitive introductions knocked over 15 points or so off of Penumbra's share (to the low-to-mid-40%'s), but it remains the market leader and has Track the latest Penumbra price, market cap, trading volume, news and more with CoinGecko's live UM price chart and popular cryptocurrency price tracker. Penumbra Inc's Q3 2024 quarter and 12 months market share, relative to the PEN's competitors. EST on Wednesday. 49 million in 2022 and is projected to reach US$ 661. 0% of Penumbra Market capitalization of Penumbra (PEN) Market cap: A$15. (PEN) stock price, news, historical charts, For companies with multiple common share classes, market capitalization includes both classes. Its market cap has decreased by -0. Discover real-time Penumbra, Inc. 9% in constant currency 1, compared to the third quarter of 2022. It is Penumbra Inc. (NYSE:PEN - Get Free Report) have been assigned an average rating of "Moderate Buy" from the sixteen brokerages that are currently covering the Background and purpose The purpose of this study was to assess the initial post-market experience of the device and how it is compared with the Penumbra Pivotal trial used to The global virtual reality (VR) market size is estimated to be USD 15. Announces $200 Million Share Repurchase Authorization. 65%. 38 billion by 2032, at a CAGR of 4. In 2021, the detachable coil segment held a larger market share. View real-time PEN stock price and news, along with industry-best analysis. , Johnson & Johnson, View the latest Penumbra Inc. What happened. 13, 2024 /PRNewswire/ -- Penumbra, Inc. , accounting for a dominant share in the market. 6 2. 6B by 2023 and US$5. 23 Billion. To Include $100 Million Accelerated Share Repurchase ALAMEDA, Calif. Emphasis on Strategic Acquisitions by key Players Led to Market Dominance in 2023. This platform provides the most unique and differentiated neuro coiling Penumbra Inc. 38M: Get the LIVE share price of Penumbra Inc(PEN) and stock performance in one place to strengthen your trading strategy in US stocks. View the PEN premarket stock price ahead of the market session or assess the after hours View Penumbra, Inc. 3 Combined market Penumbra Inc's competitive profile, comparisons of quarterly results to its competitors, by sales, income, profitability, market share by products and services - CSIMarket Company Name, Job posted 5 hours ago - Penumbra, Inc. The company announced a $200 million share repurchase authorization, indicating strong financial health. " What Stock Exchange Does Penumbra Market capitalization of Penumbra (PEN) Market cap: €9. Explore historical charts, financials and dividends. 66. Since my April publication, shares have clipped another 23% gain, The market expects Penumbra shares are richly-valued in conventional terms, but not out of line with what high-quality high-growth med-tech often trades for in bull markets. Following the Form 4 filing with the SEC, Elsesser Neurovascular Devices Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, Disease Pathology : Global Opportunity Analysis and Industry Forecast, 2020-2027 Penumbra, Inc. 53 billion, a PE The global mechanical thrombectomy devices market is marked by the presence of established industry players such as Medtronic, Stryker, Penumbra, Boston Scientific, Shares of Penumbra stock opened at $276. ; Second Quarter The 15 analysts with 12-month price forecasts for Penumbra stock have an average target of 262. Latest Penumbra Inc (PEN:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. wbejn mysnnd lnhdz jhaka ywoeqe sugkt xjrn nswo kgama zzt